View Cart  

Teva Pulls Wellbutrin Generic After FDA Study Finds Efficacy Issues

A A
Teva and Impax have ceased shipping their 300-mg generic of GlaxoSmithKline’s antidepressant Wellbutrin XL following an FDA determination that the drug is not therapeutically equivalent to its branded counterpart.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00